JLHL Jupiter Life Line Hospitals Q1 FY26 results (Apr–Jun 2025) and concall
Jupiter Life Line Hospitals reported a strong Q1 FY26 with total income growing 20.5% and EBITDA up 19.6%. However, PAT saw a slight decline of 1.6% due to higher depreciation and finance costs, a trend expected to continue. The company is progressing on greenfield projects and commissioned a new solar plant, while maintaining a net cash position. Occupancy rates saw a relative dilution due to new bed additions, but absolute occupancy and patient volumes increased.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
| Line item | Q3 FY25 | Q4 FY25 | Q1 FY26 |
|---|---|---|---|
| Revenue | 270 | 274 | 278 |
| EBITDA | 69 | 72 | 68 |
| Net profit | 49 | 44 | 43 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
